Reaction profile

The FDA adverse-event record for scrotal disorder nos

33 FDA reports name scrotal disorder nos, a lower-volume reaction in the CVM extract (VeDDRA 802). Plate stamps and neighbourhood peers follow.

#1947 of 2,481
by report volume (all reactions)
33
reports citing this reaction
33.3%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Scrotal disorder NOS has 33 reports now versus 32 in that prior snapshot: 1 more (3.1%).

Report change
+1
Death-coded reports
+0
Death-coded share
−1.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Scrotal disorder NOS changes

FDA AER · VeDDRA plate

Code 802 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 33 reports
  • DEATH-HOT 33.3%
  • LOWER-Q #1947/2481
  • PHOTO-FINISH Abnormal dexamethason…
  • SPECIES-DOG Dog · 20
  • DRUG-LEAD Carprofen · 8
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Abnormal dexamethasone suppression test (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Scrotal disorder NOS

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Abnormal dexamethason… · near33Burning mouth sensati… · near33Decreased number of s… · near33Displaced abomasum · near33Scrotal disorder NOS · this …33Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Scrotal disorder NOS

Scrotal disorder NOS: high death-coded share in the FDA AER plate

Signature read: Scrotal disorder NOS's 33.3% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 33 named reports in the openFDA extract. Death-coded share is upper-third: 11 of 33 reports (33.3% of named reports). Nearest volume peer: Abnormal dexamethasone suppression test (±0 reports). Lead species Dog (20). Lead co-reported drug Carprofen (8).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 20
Cat 7
Cattle 3
Pig 3

Breeds Most Affected

Cat (unknown) 5
Shepherd Dog - German 3
Crossbred Porcine/Pig 3
Crossbred Canine/dog 2
Terrier - Boston 2
Retriever - Labrador 2
Maltese 1
Shih Tzu 1
Domestic (unspecified) 1
Bulldog 1

Associated Drugs

Carprofen 8
Tilmicosin 7
Prednisone 3
Oclacitinib Maleate 3
Isoflurane 3
Ketamine 3
Fluralaner Chew Tablets 3
Amoxicillin 3
Carbadox 3
Atipamezole 2
Tiletamine, Zolazepam 2
Cefovecin 2
Butorphanol 2
Acepromazine 2
Moxidectin 2
Ivermectin 2
Dexmedetomidine Hydrochloride 1
Maropitant Citrate 1
Mycophenolate 1
Melatonin 1

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Scrotal disorder NOS (#1947 of 2,481 by report volume); death-coded 33.3%. PlainBreed reaction plate · death-coded share stamp 33.3% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →